Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
NEOG:NASDAQ
Neogen Corp
9,53 US$
+1,38%
(+0,13) 1D
9,53 US$
0,00% (0,00)
After hours
Closed: 1 may, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NEOG...
Açın
9,45 US$
High
9,58 US$
Low
9,29 US$
Mkt. cap
2,07 mlrd
Avg. vol.
2,60 mln
Volume
1,91 mln
52-wk high
11,42 US$
52-wk low
4,53 US$
EPS
-2,80 US$
Beta
1,97
Shares outstanding
217,67 mln
No. of employees
3K
News stories
From sources across the web
Profile
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abused and therapeutic drugs in animal treatment. In 2009, it became a vendor of the Chinese government and has been engaged in researching China-specific food safety and plant health issues. Wikipedia
About Neogen Corp
CEOJohn Adent
Employees2,97K
Founded1982
Headquarters-
SectorMedical device
Websiteneogen.com
Last report
9 apr 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
0,09/ (0,05 est.)USD
+68,76%beat
Revenue / Estimate
211,20 mln/ (204,62 mln est.)USD
+3,22%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
may 2025
avq 2025
noy 2025
fev 2026
Revenue
225,46 mln
209,19 mln
224,69 mln
211,20 mln
Cost of goods sold
137,20 mln
114,22 mln
118,01 mln
112,20 mln
Cost of revenue
137,20 mln
114,22 mln
118,01 mln
112,20 mln
Research and development expenses
6,31 mln
5,12 mln
4,56 mln
3,80 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
106,70 mln
105,94 mln
107,50 mln
98,50 mln
Operating expense
113,01 mln
111,06 mln
112,06 mln
102,30 mln
Total operating expenses
250,21 mln
225,28 mln
230,07 mln
214,50 mln
Operating income
-24,75 mln
-16,09 mln
-5,38 mln
-3,30 mln
Other non operating income
-3,35 mln
-1,10 mln
-477,00K
-3,10 mln
EBT including unusual items
-631,20 mln
43,81 mln
-20,36 mln
-20,30 mln
EBT excluding unusual items
-47,94 mln
-32,58 mln
-20,36 mln
-20,30 mln
Income tax expense
-19,01 mln
7,47 mln
-4,44 mln
-3,30 mln
Effective tax rate
3,01%
17,05%
21,80%
16,26%
Other operating expenses
-
-
-
-
Net income
-612,20 mln
36,34 mln
-15,92 mln
-17,00 mln
Net profit margin
-271,53%
17,37%
-7,09%
-8,05%
Earnings per share
0,05
0,04
0,10
0,09
Interest and investment income
644,00K
918,00K
592,00K
-
Interest expense
-17,13 mln
-16,44 mln
-14,85 mln
-13,90 mln
Net interest expenses
-16,48 mln
-15,52 mln
-14,26 mln
-13,90 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
5,51 mln
12,96 mln
23,55 mln
25,62 mln
Gain or loss from assets sale
-124,00K
-75,69 mln
267,00K
224,00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer